Surgery combined with chemotherapy significantly improves survival in gastric cancer patients.

• Median survival for intestinal-type cancers was 45.2 months with surgery and chemotherapy, versus just 5.1 months for palliative treatment.
• Patients with diffuse-type cancers exceeded 128 months median survival with the same approach, compared to 6.3 months with palliative care.

Palliative chemotherapy and radiotherapy also enhanced survival compared to supportive care alone.

• Treatment stage strongly impacts outcomes; advanced stages correlate with lower survival rates.